CARBOGEN AMCIS delivers leading process research services that support the drug substance development process. CARBOGEN AMCIS' API manufacture concentrates on producing the supplies necessary to conduct clinical trials through Phase II. Our typical batch sizes range from 50 g to 50 kg and are prepared to the highest standards of Good Manufacturing Practice (cGMP).

Our services are tailored to the individual needs of each client from initial route finding through to cGMP production, with a focus on three areas:

• Route Finding / Feasibility Studies
• Process Optimization
• Enabling / Scale-Up

Early Stage Performance

Throughout the process, CARBOGEN AMCIS infuses each stage of our project work with our highly organized, structured approach. Our tried and tested processes translate to a time and cost efficiency that benefits our clients and their projects time and time again. When necessary, we integrate our services with the late stage services  to deliver a comprehensive service to clients.

As a leading drug development services provider, CARBOGEN AMCIS is equipped with an advanced laboratory environment containing cutting-edge technology and an unmatched capacity to perform process research and API manufacturing.

The breadth of equipment available at our Aarau and Neuland sites translates to increased flexibility and capacity to ensure our capability to complete projects on time and on budget.